These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 20308889)

  • 1. New diagnostic devices in heart failure.
    Schlendorf KH; Russell SD
    Curr Opin Cardiol; 2010 May; 25(3):262-7. PubMed ID: 20308889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New approaches to monitoring heart failure before symptoms appear.
    Abraham WT
    Rev Cardiovasc Med; 2006; 7 Suppl 1():S33-41. PubMed ID: 16955058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Device monitoring of intrathoracic impedance: clinical observations from a patient registry.
    Andriulli J
    Am J Cardiol; 2007 May; 99(10A):23G-8G. PubMed ID: 17512419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct left atrial pressure monitoring in ambulatory heart failure patients: initial experience with a new permanent implantable device.
    Ritzema J; Melton IC; Richards AM; Crozier IG; Frampton C; Doughty RN; Whiting J; Kar S; Eigler N; Krum H; Abraham WT; Troughton RW
    Circulation; 2007 Dec; 116(25):2952-9. PubMed ID: 18056531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Continuous monitoring of intrathoracic impedance and right ventricular pressures in patients with heart failure.
    Vanderheyden M; Houben R; Verstreken S; Ståhlberg M; Reiters P; Kessels R; Braunschweig F
    Circ Heart Fail; 2010 May; 3(3):370-7. PubMed ID: 20197559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can monitoring of intrathoracic impedance reduce morbidity and mortality in patients with chronic heart failure? Rationale and design of the Diagnostic Outcome Trial in Heart Failure (DOT-HF).
    Braunschweig F; Ford I; Conraads V; Cowie MR; Jondeau G; Kautzner J; Lunati M; Munoz Aguilera R; Man Yu C; Marijianowski M; Borggrefe M; van Veldhuisen DJ;
    Eur J Heart Fail; 2008 Sep; 10(9):907-16. PubMed ID: 18715826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Telemonitoring in chronic heart failure.
    Hasan A; Paul V
    Eur Heart J; 2011 Jun; 32(12):1457-64. PubMed ID: 21289040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fundamentals of intrathoracic impedance monitoring in heart failure.
    Wang L
    Am J Cardiol; 2007 May; 99(10A):3G-10G. PubMed ID: 17512421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proactive monitoring: implications of implantable devices for future heart failure management.
    Daleiden-Burns A; Stiles P
    Crit Care Nurs Q; 2007; 30(4):321-8. PubMed ID: 17873568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrating device-based monitoring into clinical practice: insights from a large heart failure clinic.
    Small RS
    Am J Cardiol; 2007 May; 99(10A):17G-22G. PubMed ID: 17512418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The implantable hemodynamic monitoring system.
    Wadas TM
    Crit Care Nurse; 2005 Oct; 25(5):14-6, 18-20, 22-4; quiz 27. PubMed ID: 16183749
    [No Abstract]   [Full Text] [Related]  

  • 12. Rationale and design of a prospective trial to assess the sensitivity and positive predictive value of implantable intrathoracic impedance monitoring in the prediction of heart failure hospitalizations: the SENSE-HF study.
    Cowie MR; Conraads V; Tavazzi L; Yu CM;
    J Card Fail; 2009 Jun; 15(5):394-400. PubMed ID: 19477399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. OptiVol fluid status monitoring with an implantable cardiac device: a heart failure management system.
    Yamokoski LM; Haas GJ; Gans B; Abraham WT
    Expert Rev Med Devices; 2007 Nov; 4(6):775-80. PubMed ID: 18035943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Device therapy in advanced heart failure: what to put in and what to turn off: remote telemonitoring and implantable hemodynamic devices for advanced heart failure monitoring in the ambulatory setting and the evolving role of cardiac resynchronization therapy.
    Smith SA; Abraham WT
    Congest Heart Fail; 2011; 17(5):220-6. PubMed ID: 21906246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intrathoracic impedance monitoring in patients with heart failure: correlation with fluid status and feasibility of early warning preceding hospitalization.
    Yu CM; Wang L; Chau E; Chan RH; Kong SL; Tang MO; Christensen J; Stadler RW; Lau CP
    Circulation; 2005 Aug; 112(6):841-8. PubMed ID: 16061743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of device diagnostics as an educational tool to improve patient adherence.
    Rathman L
    Am J Cardiol; 2007 May; 99(10A):29G-33G. PubMed ID: 17512420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of implantable devices for continuous ambulatory monitoring of central hemodynamic values in heart failure patients.
    Bennett T; Kjellstrom B; Taepke R; Ryden L
    Pacing Clin Electrophysiol; 2005 Jun; 28(6):573-84. PubMed ID: 15955193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in intrathoracic impedance are associated with subsequent risk of hospitalizations for acute decompensated heart failure: clinical utility of implanted device monitoring without a patient alert.
    Small RS; Wickemeyer W; Germany R; Hoppe B; Andrulli J; Brady PA; Labeau M; Koehler J; Sarkar S; Hettrick DA; Tang WH
    J Card Fail; 2009 Aug; 15(6):475-81. PubMed ID: 19643357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic monitoring strategies in heart failure management.
    Piccini JP; Hranitzky P
    Am Heart J; 2007 Apr; 153(4 Suppl):12-7. PubMed ID: 17394898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of implantable sensors for management of heart failure.
    Kadhiresan K; Carlson G
    Stud Health Technol Inform; 2004; 108():219-27. PubMed ID: 15718650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.